If you're looking big pharma, look no further than Actavis
The company has been in dealmaking mode for some time now, and it’s acquisitions are getting bigger, filling holes in its drug portfolio and increasing company revenue.
Bond links: Junk-bond risks escalate
In today’s bond linkfest, we have links to columns discussing corporate debtors not paying down their borrowing, whether or not investors really understand bond risks, and more.
An old Wall Street saying is that a rising tide lifts all boats, but no matter which way the market is moving, there are stocks that will always go their own way. Here are six worth watching regardless of market trend.
/conga/trading-deck/columnist-competition.html
234012
Hot Mentions
